Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer
Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesothelioma
Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesothelioma
Add comment